Core Insights - The probiotic industry is increasingly relying on clinical evidence as a foundation for development, driven by consumer awareness, regulatory standardization, and the demand for genuine product value [1] - The Bifidobacterium animalis subsp. lactis BLa80 strain, isolated from healthy breast milk in China's Sichuan Plateau, has established a comprehensive scientific evidence system and has been officially listed for infant food use [2][4] - BLa80 has successfully passed both self-affirmed GRAS and FDA GRAS certifications, marking it as the first strain in mainland China to achieve dual GRAS status, which enhances the domestic probiotic industry and reduces reliance on imported strains [2][5] Industry Trends - The focus of probiotic research has shifted from broad strain categories to precise validation of specific strain functions, emphasizing the importance of a complete evidence chain from safety assessments to clinical trials and regulatory approvals [8] - The development model of BLa80, which integrates local microbial resources, international and domestic certifications, and comprehensive clinical research covering the entire infant growth cycle, is expected to drive quality improvement and technological advancement in the domestic probiotic industry [8]

Core Insights - The conference highlighted the innovative application of probiotics in the snack food industry, focusing on health and nutrition upgrades through diverse product forms [1][10]. Group 1: Probiotic Innovations - The "Probiotic+" strategy aims to expand application boundaries and integrate health upgrades into snack foods, creating differentiated competitive advantages [2]. - Key probiotic strains showcased include BLa80, LRa05, Akk11, and BC99, each with extensive clinical research backing their health benefits [2][3][7]. - BLa80 is recognized for its clinical studies on infant health and gut regulation, while LRa05 focuses on women's health and allergy improvement [2][7]. Group 2: Clinical Evidence and Research - The company emphasizes the importance of clinical evidence in validating probiotic functions and enhancing health food credibility [5][7]. - A robust clinical research system has been established, covering various demographics and health aspects, including gastrointestinal health and emotional well-being [7]. - The commitment to clinical research is seen as essential for building consumer trust and supporting product efficacy claims [7]. Group 3: Product Development and Consumer Trends - Innovative product forms such as probiotic gummies, mineral water, and chewable tablets cater to consumer demands for convenient and enjoyable health solutions [8]. - The focus on integrating probiotics into everyday consumption aligns with the growing consumer interest in healthy snacks, with 76% of consumers seeking healthier options [2]. Group 4: Industry Vision and Future Directions - The conference underscored the need for the snack food industry to innovate beyond traditional methods, integrating health strategies into product development [10]. - The vision of promoting human health and environmental sustainability through probiotics aligns with industry calls for sustainable development [10].